Alexander Bartram
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexander Bartram has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Rebecca C. Fitzgerald
Early Cancer Institute, University of Cambridge, Cambridge, UK
3 shared publications - Adam Freeman
Early Cancer Institute, University of Cambridge, Cambridge, UK
2 shared publications Ahmad Miremadi
Department of Pathology, Cambridge University Hospital NHS Trust, Cambridge, UK
2 shared publications- Alvin Wei Tian Ng
Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK
2 shared publications Daniel Jacobson
Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK
2 shared publicationsGinny Devonshire
Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 16 April 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (5) , 1805-1816
Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinoma
Cancer generally takes years to evolve, and early diagnosis can prevent life-threatening cancer. Establishing a link between precancerous states and cancer is essential for effective screening and prevention. Esophageal adenocarcinoma (EAC) is an increasingly prevalent, poor-outcome cancer, and its presumed precursor, Barrett’s esophagus (BE), characterized by intestinal metaplasia, is evident in only about half of cases. Here to test whether BE is a prerequisite to EAC, we integrated epidemiological and clinical characteristics in a prospective cohort of 3,100 patients with EAC for any evidence of BE (BE-positive and BE-negative) and compared genomic features using a subset of 710 patients with whole-genome sequencing and 87 patients (380 samples) with multiregional whole-exome sequencing. Demographic and genomic features typically associated with BE were observed across BE-positive and BE-negative EAC cases. Notably, molecular features consistent with early BE evolution were detected in both phenotypes. Advanced tumor stage was the only variable that corresponded with increased likelihood of BE-negative EAC, including in some patients with a previous BE diagnosis. Phylogenetic analyses revealed shared evolutionary trajectories, and spatial transcriptomic and proteomic analyses demonstrated intestinal metaplasia-associated lineage markers in both groups. These findings suggest a single pathway to EAC, with implications for early diagnosis and prevention strategies.
- 16 April 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (5) , 1805-1816
Top Cited PapersOpen AccessIntegrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinoma
Cancer generally takes years to evolve, and early diagnosis can prevent life-threatening cancer. Establishing a link between precancerous states and cancer is essential for effective screening and prevention. Esophageal adenocarcinoma (EAC) is an increasingly prevalent, poor-outcome cancer, and its presumed precursor, Barrett’s esophagus (BE), characterized by intestinal metaplasia, is evident in only about half of cases. Here to test whether BE is a prerequisite to EAC, we integrated epidemiological and clinical characteristics in a prospective cohort of 3,100 patients with EAC for any evidence of BE (BE-positive and BE-negative) and compared genomic features using a subset of 710 patients with whole-genome sequencing and 87 patients (380 samples) with multiregional whole-exome sequencing. Demographic and genomic features typically associated with BE were observed across BE-positive and BE-negative EAC cases. Notably, molecular features consistent with early BE evolution were detected in both phenotypes. Advanced tumor stage was the only variable that corresponded with increased likelihood of BE-negative EAC, including in some patients with a previous BE diagnosis. Phylogenetic analyses revealed shared evolutionary trajectories, and spatial transcriptomic and proteomic analyses demonstrated intestinal metaplasia-associated lineage markers in both groups. These findings suggest a single pathway to EAC, with implications for early diagnosis and prevention strategies.
- Open Access
- 8 July 2025
- Published by SAGE Publications in Foregut: The Journal of the American Foregut Society
- Vol. 5 (3) , 300-305
A Patient With Risk Factors for Barrett’s Esophagus (BE) Undergoes Screening With a Cellular Collection Device
Minimally invasive esophageal cellular collection devices such as the Capsule Sponge may offer the potential for targeted screening of high-risk patients. The capsule sponge has been shown to be a safe, accurate and effective means of detecting Barrett’s esophagus. Here, we explore two potential real-life scenarios that could occur in a future screening or case finding programme. Firstly, when the capsule sponge test result is positive but confirmatory endoscopy demonstrates <1cm of columnar epithelium and secondly when subsequent endoscopy identifies gastric intestinal neoplasia. We discuss the clinical implication of the result and suggest how these patients could potentially be followed up in the future.
- 8 July 2025
- Published by SAGE Publications in Foregut: The Journal of the American Foregut Society
- Vol. 5 (3) , 300-305
Open AccessA Patient With Risk Factors for Barrett’s Esophagus (BE) Undergoes Screening With a Cellular Collection Device
Minimally invasive esophageal cellular collection devices such as the Capsule Sponge may offer the potential for targeted screening of high-risk patients. The capsule sponge has been shown to be a safe, accurate and effective means of detecting Barrett’s esophagus. Here, we explore two potential real-life scenarios that could occur in a future screening or case finding programme. Firstly, when the capsule sponge test result is positive but confirmatory endoscopy demonstrates <1cm of columnar epithelium and secondly when subsequent endoscopy identifies gastric intestinal neoplasia. We discuss the clinical implication of the result and suggest how these patients could potentially be followed up in the future.
- Open Access
- 3 March 2025
- Published by Springer Nature in Research Square
Integrated epidemiogical and genomic data yields insights into the relationship between precancer and cancer states of the oesophagus
Cancer generally takes years to evolve, and early diagnosis can prevent life-threatening cancer 1,2 . Symptomatic, advanced cancers often lack evidence of a precancer at diagnosis and yet, if the link between a precancerous state and cancer can be proven, the opportunity arises for screening and prevention. Oesophageal adenocarcinoma (EAC) is an increasingly prevalent, 3 poor outcome cancer and its presumed precursor, Barrett’s oesophagus (BE) is only evident in around half of cases 4,5 . To test the hypothesis that BE is not a pre-requisite to EAC we classified a prospective cohort of 3,100 EAC patients for any evidence of BE and compared the epidemiological, clinical and genomic characteristics. Our findings demonstrate that there are specific demographic and genomic features observed in BE that also correlate strongly with EAC, regardless of the presence of a BE phenotype. Further we found evidence for the earliest features of BE evolution in both BE-negative and BE-positive EAC phenotypes. Advanced tumour stage was the only variable that corresponded with increased likelihood of BE-negative EAC, including in some patients with a prior diagnosis of Barrett’s. The role of a single BE-mediated pathway to EAC has implications for early diagnosis strategies. We anticipate that our methodology combining large epidemiological and genomic datasets with respect to phenotype could help establish the significance of other precancer states.
- 3 March 2025
- Published by Springer Nature in Research Square
Open AccessIntegrated epidemiogical and genomic data yields insights into the relationship between precancer and cancer states of the oesophagus
Cancer generally takes years to evolve, and early diagnosis can prevent life-threatening cancer 1,2 . Symptomatic, advanced cancers often lack evidence of a precancer at diagnosis and yet, if the link between a precancerous state and cancer can be proven, the opportunity arises for screening and prevention. Oesophageal adenocarcinoma (EAC) is an increasingly prevalent, 3 poor outcome cancer and its presumed precursor, Barrett’s oesophagus (BE) is only evident in around half of cases 4,5 . To test the hypothesis that BE is not a pre-requisite to EAC we classified a prospective cohort of 3,100 EAC patients for any evidence of BE and compared the epidemiological, clinical and genomic characteristics. Our findings demonstrate that there are specific demographic and genomic features observed in BE that also correlate strongly with EAC, regardless of the presence of a BE phenotype. Further we found evidence for the earliest features of BE evolution in both BE-negative and BE-positive EAC phenotypes. Advanced tumour stage was the only variable that corresponded with increased likelihood of BE-negative EAC, including in some patients with a prior diagnosis of Barrett’s. The role of a single BE-mediated pathway to EAC has implications for early diagnosis strategies. We anticipate that our methodology combining large epidemiological and genomic datasets with respect to phenotype could help establish the significance of other precancer states.
- 1 March 2021
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 94, 102158
Breast MRI in DCIS size estimation, breast-conserving surgery and oncoplastic breast surgery
- 1 March 2021
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 94, 102158
Breast MRI in DCIS size estimation, breast-conserving surgery and oncoplastic breast surgery